SAN DIEGO -- Genetic test maker Sequenom Inc. said Monday it will collaborate with Illumina on a new test that detects fetal abnormalities that can lead to Down syndrome.
Under the agreement Sequenom will use Illumina's genetic sequencing equipment and other technology to develop a test for pregnant women that can detect high levels of chromosome 21, which is associated with Down syndrome.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment